Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Sugar-Based Excipients Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for sugar-based excipients has experienced consistent expansion. Projections indicate a rise from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 4.1%. This growth trajectory during the past period is attributable to several key factors: an upswing in pharmaceutical manufacturing, the extensive application of lactose and sucrose as excipients, an increase in generic drug manufacturing, a heightened demand for solid oral dosage forms, and the well-established regulatory approval for sugar-based excipients.
The market for sugar-based excipients is poised for consistent expansion over the upcoming years, projecting a valuation of $1.81 billion by 2030 with a compound annual growth rate (CAGR) of 3.8%. This anticipated growth is fueled by several key factors, including the increasing preference for low-calorie and non-cariogenic alternatives, a heightened demand for formulations tailored to pediatric and geriatric populations, the burgeoning biopharmaceutical production sector, a growing emphasis on sourcing clean-label excipients, and substantial investments dedicated to driving innovation within the excipient space. During this forecast period, prevailing trends expected to shape the market include a greater embrace of sugar alcohol-based excipients, a surge in demand for patient-centric formulations, the wider adoption of multifunctional excipients, the proliferation of orally disintegrating dosage forms, and a more rigorous focus on maintaining high standards for excipient purity.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21291&type=smp
Sugar-Based Excipients Market Growth Drivers And Industry Catalysts
The increasing prevalence of pharmaceutical products is anticipated to be a key driver for the expansion of the sugar-based excipients market in the future. The pharmaceutical sector is dedicated to discovering, developing, manufacturing, and commercializing medicines to enhance health results. This industry’s demand is on the rise, fueled by a growing need for novel therapies, progress in drug innovation techniques, and escalating global health requirements. Within pharmaceuticals, sugar-based excipients serve critical roles such as bulking agents, binding agents, and stabilizers, thereby improving drug composition, palatability, and absorption. As an illustration, by August 2025, it was reported by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade organization in Belgium representing the pharmaceutical industry, that health industries allocated approximately $281.2 billion (€258.1 billion) towards research and development activities in 2023, representing 20.5% of all business R&D investments globally. Consequently, the burgeoning popularity of pharmaceuticals is directly contributing to the growth of the sugar-based excipients market.
Sugar-Based Excipients Market Segmentation Trends And Revenue Drivers
The sugar-based excipients market covered in this report is segmented –
1) By Product: Actual Sugar, Artificial Sweeteners, Sugar Alcohol
2) By Dosage Form: Liquid Dosage Forms, Semi-Solid Dosage Forms, Solid Dosage Forms
3) By Application: Diluents, Fillers, Tonicity Agents, Flavoring Agents
4) By End User: Pharmaceutical Industry, Food And Beverage Industry, Cosmetics And Personal Care Industry
Subsegments:
1) By Actual Sugar: Sucrose, Lactose, Dextrose, Fructose, Other Actual Sugars
2) By Artificial Sweeteners: Aspartame, Saccharin, Sucralose, Acesulfame K, Other Artificial Sweeteners
3) By Sugar Alcohol: Mannitol, Sorbitol, Xylitol, Maltitol, Other Sugar Alcohols
#Sugar-Based Excipients Market Trends Influencing Long-Term Demand
Leading entities within the sugar-based excipients sector are focusing their efforts on pioneering advancements, particularly in the realm of next-generation mannitol, with the overarching goal of bolstering drug longevity, elevating dissolution rates, and refining overall formulation efficacy for pharmaceutical use. These sophisticated mannitol formulations are meticulously crafted to achieve enhanced drug stability, better drug solubility, and optimized tablet compression, thereby ensuring superior outcomes in pharmaceutical applications. As an illustrative example, in May of 2023, Roquette, a French provider specializing in plant-derived components and pharmaceutical/nutraceutical excipients, unveiled PEARLITOL® ProTec, a novel excipient resulting from the co-processing of mannitol and maize starch, at the Vitafoods Europe exhibition. This innovative product boasts a controlled water activity level of less than 0.20 and a moisture concentration under 1%, making it particularly adept at preserving the integrity of probiotics and other compounds susceptible to moisture. The excipient furthermore exhibits remarkable compressibility and fluidization characteristics, facilitating its seamless integration into direct-compression tablets, stick packs, or sachets without the necessity for any prerequisite drying procedures. Adhering strictly to the standards set forth by major pharmacopeias, it is engineered to empower nutraceutical producers in meeting rigorous stability regulations and compliance demands with greater efficiency.
Sugar-Based Excipients Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the sugar-based excipients market are Cargill Incorporated, Archer Daniels Midland Company, Associated British Foods PLC, DuPont de Nemours Inc., IFF Pharmaceuticals Solutions, Ingredion Incorporated, Tereos S.A., Roquette Frères S.A., IMCD N.V., Ashland Global Holdings Inc., Tate & Lyle PLC, Colorcon Inc., DFE Pharma, Emilio Castelli S.R.L., Pfanstiehl Inc., Meggle AG, Scope Ingredients Pvt. Ltd., Citron Scientific, MB Sugars & Pharmaceuticals, Prinova Group LLC, Global Sweeteners Holdings LLC, CSM Ingredients
Access The Complete Sugar-Based Excipients Market Report:
https://www.thebusinessresearchcompany.com/report/sugar-based-excipients-global-market-report
Sugar-Based Excipients Market Geographic Distribution And Regional Opportunities
North Americawas the largest region in the sugar-based excipients market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the sugar-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
